Predicting Effective Adaptation to Breast Cancer to Help Women BOUNCE Back: Protocol for a Multicenter Clinical Pilot Study

Greta Pettini, Virginia Sanchini, Ruth Pat-Horenczyk, Berta Sousa, Marianna Masiero, Chiara Marzorati, Viviana Enrica Galimberti, Elisabetta Munzone, Johanna Mattson, Leena Vehmanen, Meri Utriainen, Ilan Roziner, Raquel Lemos, Diana Frasquilho, Fatima Cardoso, Albino J Oliveira-Maia, Eleni Kolokotroni, Georgios Stamatakos, Riikka-Leena Leskelä, Ira Haavisto, Juha Salonen, Robert Richter, Evangelos Karademas, Paula Poikonen-Saksela, Ketti Mazzocco, Greta Pettini, Virginia Sanchini, Ruth Pat-Horenczyk, Berta Sousa, Marianna Masiero, Chiara Marzorati, Viviana Enrica Galimberti, Elisabetta Munzone, Johanna Mattson, Leena Vehmanen, Meri Utriainen, Ilan Roziner, Raquel Lemos, Diana Frasquilho, Fatima Cardoso, Albino J Oliveira-Maia, Eleni Kolokotroni, Georgios Stamatakos, Riikka-Leena Leskelä, Ira Haavisto, Juha Salonen, Robert Richter, Evangelos Karademas, Paula Poikonen-Saksela, Ketti Mazzocco

Abstract

Background: Despite the continued progress of medicine, dealing with breast cancer is becoming a major socioeconomic challenge, particularly due to its increasing incidence. The ability to better manage and adapt to the entire care process depends not only on the type of cancer but also on the patient's sociodemographic and psychological characteristics as well as on the social environment in which a person lives and interacts. Therefore, it is important to understand which factors may contribute to successful adaptation to breast cancer. To our knowledge, no studies have been performed on the combination effect of multiple psychological, biological, and functional variables in predicting the patient's ability to bounce back from a stressful life event, such as a breast cancer diagnosis. Here we describe the study protocol of a multicenter clinical study entitled "Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back" or, in short, BOUNCE.

Objective: The aim of the study is to build a quantitative mathematical model of factors associated with the capacity for optimal adjustment to cancer and to study resilience through the cancer continuum in a population of patients with breast cancer.

Methods: A total of 660 women with breast cancer will be recruited from five European cancer centers in Italy, Finland, Israel, and Portugal. Biomedical and psychosocial variables will be collected using the Noona Healthcare platform. Psychosocial, sociodemographic, lifestyle, and clinical variables will be measured every 3 months, starting from presurgery assessment (ie, baseline) to 18 months after surgery. Temporal data mining, time-series prediction, sequence classification methods, clustering time-series data, and temporal association rules will be used to develop the predictive model.

Results: The recruitment process stared in January 2019 and ended in November 2021. Preliminary results have been published in a scientific journal and are available for consultation on the BOUNCE project website. Data analysis and dissemination of the study results will be performed in 2022.

Conclusions: This study will develop a predictive model that is able to describe individual resilience and identify different resilience trajectories along the care process. The results will allow the implementation of tailored interventions according to patients' needs, supported by eHealth technologies.

Trial registration: ClinicalTrials.gov NCT05095675; https://ichgcp.net/clinical-trials-registry/NCT05095675.

International registered report identifier (irrid): DERR1-10.2196/34564.

Keywords: cancer; coping; decision-making; personality; quality of life; resilience.

Conflict of interest statement

Conflicts of Interest: AJOM was the national coordinator for Portugal of a noninterventional study (EDMS-ERI-143085581, 4.0) to characterize a treatment-resistant depression cohort in Europe, sponsored by Janssen-Cilag, Ltd (2019-2020); is the recipient of a grant from Schuhfried GmbH for the norming and validation of cognitive tests; and is the national coordinator for Portugal of trials related to psilocybin therapy for treatment-resistant depression, sponsored by Compass Pathways, Ltd (EudraCT [European Union Drug Regulating Authorities Clinical Trials Database] Nos. 2017-003288-36 and 2020-001348-25), and esketamine for treatment-resistant depression, sponsored by Janssen-Cilag, Ltd (EudraCT No. 2019-002992-33). JS is employed by Varian Medical System Inc, which is the manufacturer of the Noona patient-reported outcomes platform.

©Greta Pettini, Virginia Sanchini, Ruth Pat-Horenczyk, Berta Sousa, Marianna Masiero, Chiara Marzorati, Viviana Enrica Galimberti, Elisabetta Munzone, Johanna Mattson, Leena Vehmanen, Meri Utriainen, Ilan Roziner, Raquel Lemos, Diana Frasquilho, Fatima Cardoso, Albino J Oliveira-Maia, Eleni Kolokotroni, Georgios Stamatakos, Riikka-Leena Leskelä, Ira Haavisto, Juha Salonen, Robert Richter, Evangelos Karademas, Paula Poikonen-Saksela, Ketti Mazzocco. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 12.10.2022.

Figures

Figure 1
Figure 1
Schematic illustration of the multiple factors affecting the resilience trajectory and outcomes. QoL: quality of life (adapted from Poikonen-Saksela [44], with permission from Paula Poikonen-Saksela).

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424. doi: 10.3322/caac.21492. doi: 10.3322/caac.21492.
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020 Jan;70(1):7–30. doi: 10.3322/caac.21590. doi: 10.3322/caac.21590.
    1. Rutter M. Implications of resilience concepts for scientific understanding. Ann N Y Acad Sci. 2006 Dec;1094:1–12. doi: 10.1196/annals.1376.002.1094/1/1
    1. Southwick SM, Bonanno GA, Masten AS, Panter-Brick C, Yehuda R. Resilience definitions, theory, and challenges: Interdisciplinary perspectives. Eur J Psychotraumatol. 2014;5:25338. doi: 10.3402/ejpt.v5.25338. 25338
    1. Cosco TD, Howse K, Brayne C. Healthy ageing, resilience and wellbeing. Epidemiol Psychiatr Sci. 2017 Dec;26(6):579–583. doi: 10.1017/S2045796017000324. S2045796017000324
    1. Tramontano D, De Amicis F. Is the secret for a successful aging to keep track of cancer pathways? J Cell Physiol. 2018 Nov;233(11):8467–8476. doi: 10.1002/jcp.26825.
    1. Ben-Shaanan TL, Schiller M, Azulay-Debby H, Korin B, Boshnak N, Koren T, Krot M, Shakya J, Rahat MA, Hakim F, Rolls A. Modulation of anti-tumor immunity by the brain's reward system. Nat Commun. 2018 Jul 13;9(1):2723. doi: 10.1038/s41467-018-05283-5. doi: 10.1038/s41467-018-05283-5.10.1038/s41467-018-05283-5
    1. Felger JC, Li Z, Haroon E, Woolwine BJ, Jung MY, Hu X, Miller AH. Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry. 2016 Oct;21(10):1358–1365. doi: 10.1038/mp.2015.168. mp2015168
    1. Bruenig D, Morris CP, Mehta D, Harvey W, Lawford B, Young RM, Voisey J. Nitric oxide pathway genes (NOS1AP and NOS1) are involved in PTSD severity, depression, anxiety, stress and resilience. Gene. 2017 Aug 20;625:42–48. doi: 10.1016/j.gene.2017.04.048.S0378-1119(17)30318-9
    1. Takeuchi A, Saito T. CD4 CTL, a cytotoxic subset of CD4 T cells, their differentiation and function. Front Immunol. 2017;8:194. doi: 10.3389/fimmu.2017.00194. doi: 10.3389/fimmu.2017.00194.
    1. Walker FR, Pfingst K, Carnevali L, Sgoifo A, Nalivaiko E. In the search for integrative biomarker of resilience to psychological stress. Neurosci Biobehav Rev. 2017 Mar;74(Pt B):310–320. doi: 10.1016/j.neubiorev.2016.05.003.S0149-7634(15)30360-2
    1. Bonanno GA, Galea S, Bucciarelli A, Vlahov D. What predicts psychological resilience after disaster? The role of demographics, resources, and life stress. J Consult Clin Psychol. 2007 Oct;75(5):671–682. doi: 10.1037/0022-006X.75.5.671.2007-13640-001
    1. Carver CS. Enhancing adaptation during treatment and the role of individual differences. Cancer. 2005 Dec 01;104(11 Suppl):2602–2607. doi: 10.1002/cncr.21247. doi: 10.1002/cncr.21247.
    1. Molina Y, Yi JC, Martinez-Gutierrez J, Reding KW, Yi-Frazier JP, Rosenberg AR. Resilience among patients across the cancer continuum: Diverse perspectives. Clin J Oncol Nurs. 2014 Feb;18(1):93–101. doi: 10.1188/14.CJON.93-101. 27115G573867G566
    1. Di Giacomo D, Cannita K, Ranieri J, Cocciolone V, Passafiume D, Ficorella C. Breast cancer and psychological resilience among young women. J Psychopathol. 2016;22:191–195.
    1. Pravettoni G, Gorini A. A P5 cancer medicine approach: Why personalized medicine cannot ignore psychology. J Eval Clin Pract. 2011 Aug;17(4):594–596. doi: 10.1111/j.1365-2753.2011.01709.x.
    1. Pravettoni G, Mazzocco K, Gorini A, Curigliano G. Understanding cognitive processes behind acceptance or refusal of phase I trials. Crit Rev Oncol Hematol. 2016 Apr;100:69–73. doi: 10.1016/j.critrevonc.2016.01.023.S1040-8428(16)30023-3
    1. Galli F, Scotto L, Ravenda S, Zampino MG, Pravettoni G, Mazzocco K. Personality factors in colorectal cancer: A systematic review. Front Psychol. 2021;12:590320. doi: 10.3389/fpsyg.2021.590320. doi: 10.3389/fpsyg.2021.590320.
    1. Garnefski N, Kraaij V, Spinhoven P. Negative life events, cognitive emotion regulation and emotional problems. Pers Individ Dif. 2001 Jun;30(8):1311–1327. doi: 10.1016/S0191-8869(00)00113-6.
    1. Li L, Zhu X, Yang Y, He J, Yi J, Wang Y, Zhang J. Cognitive emotion regulation: Characteristics and effect on quality of life in women with breast cancer. Health Qual Life Outcomes. 2015 May 06;13:51. doi: 10.1186/s12955-015-0242-4. 10.1186/s12955-015-0242-4
    1. Hamama-Raz Y, Pat-Horenczyk R, Perry S, Ziv Y, Bar-Levav R, Stemmer SM. The effectiveness of group intervention on enhancing cognitive emotion regulation strategies in breast cancer patients: A 2-year follow-up. Integr Cancer Ther. 2016 Jun;15(2):175–182. doi: 10.1177/1534735415607318. 1534735415607318
    1. Nolen-Hoeksema S, Aldao A. Gender and age differences in emotion regulation strategies and their relationship to depressive symptoms. Pers Individ Dif. 2011 Oct;51(6):704–708. doi: 10.1016/j.paid.2011.06.012.
    1. Wang Y, Yi J, He J, Chen G, Li L, Yang Y, Zhu X. Cognitive emotion regulation strategies as predictors of depressive symptoms in women newly diagnosed with breast cancer. Psychooncology. 2014 Jan;23(1):93–99. doi: 10.1002/pon.3376.
    1. Mazzocco K, Masiero M, Carriero MC, Pravettoni G. The role of emotions in cancer patients' decision-making. Ecancermedicalscience. 2019;13:914. doi: 10.3332/ecancer.2019.914. can-13-914
    1. Gorini A, Riva S, Marzorati C, Cropley M, Pravettoni G. Rumination in breast and lung cancer patients: Preliminary data within an Italian sample. Psychooncology. 2018 Feb;27(2):703–705. doi: 10.1002/pon.4468.
    1. Novakov I, Popovic-Petrovic S. Personality traits as predictors of the affective state in patients after breast cancer surgery. Arch Oncol. 2017;23(1):3–8. doi: 10.2298/aoo1701003n.
    1. BorjAlilu S, Kaviani A, Helmi S, Karbakhsh M, Mazaheri M. Exploring the role of self-efficacy for coping with breast cancer: A systematic review. Arch Breast Cancer. 2017 May;4(2):42–57. doi: 10.19187/abc.20174242-57.
    1. Wills TA, Bantum EO. Social support, self-regulation, and resilience in two populations: General-population adolescents and adult cancer survivors. J Soc Clin Psychol. 2012 Jun;31(6):568–592. doi: 10.1521/jscp.2012.31.6.568.
    1. Rolland JS. Cancer and the family: An integrative model. Cancer. 2005 Dec 01;104(11 Suppl):2584–2595. doi: 10.1002/cncr.21489. doi: 10.1002/cncr.21489.
    1. Faccio F, Renzi C, Giudice AV, Pravettoni G. Family resilience in the oncology setting: Development of an integrative framework. Front Psychol. 2018;9:666. doi: 10.3389/fpsyg.2018.00666. doi: 10.3389/fpsyg.2018.00666.
    1. von Bertalanffy L. General System Theory: Foundations, Development, Applications. New York, NY: George Braziller; 2003.
    1. Faccio F, Gandini S, Renzi C, Fioretti C, Crico C, Pravettoni G. Development and validation of the Family Resilience (FaRE) Questionnaire: An observational study in Italy. BMJ Open. 2019 Jun 05;9(6):e024670. doi: 10.1136/bmjopen-2018-024670. bmjopen-2018-024670
    1. Deshields T, Heiland M, Kracen A, Dua P. Resilience in adults with cancer: Development of a conceptual model. Psychooncology. 2016 Jan;25(1):11–18. doi: 10.1002/pon.3800.
    1. Didier F, Radice D, Maldifassi A, Gatti G, Luini A, Leonardi C, Lupo F, Rotmensz N, Santillo B, Galimberti V, Goldhirsch A. Do early breast cancer patients with only sentinel lymph node biopsy experience lower psychological morbidity over time? Breast J. 2012;18(6):622–624. doi: 10.1111/tbj.12024.
    1. Longman AJ, Braden CJ, Mishel MH. Side-effects burden, psychological adjustment, and life quality in women with breast cancer: Pattern of association over time. Oncol Nurs Forum. 1999 Jun;26(5):909–915.
    1. Simon AE, Robb KA. Cancer: breast. In: Ayers S, Baum A, McManus C, Newman S, Wallston K, Weinman J, West R, editors. Cambridge Handbook of Psychology, Health and Medicine. Cambridge, UK: Cambridge University Press; 2007. p. 577.
    1. Jacobsen PB, Donovan KA. Psychological Co-morbidities of Physical Illness. New York, NY: Springer; 2011. Psychological co-morbidities of cancer; pp. 163–205.
    1. Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: Five year observational cohort study. BMJ. 2005 Mar 26;330(7493):702. doi: 10.1136/bmj.38343.670868.D3. bmj.38343.670868.D3
    1. Antoni MH, Lechner SC, Kazi A, Wimberly SR, Sifre T, Urcuyo KR, Phillips K, Glück S, Carver CS. How stress management improves quality of life after treatment for breast cancer. J Consult Clin Psychol. 2006 Dec;74(6):1143–1152. doi: 10.1037/0022-006X.74.6.1152. 2006-22003-015
    1. Renzi C, Riva S, Masiero M, Pravettoni G. The choice dilemma in chronic hematological conditions: Why choosing is not only a medical issue? A psycho-cognitive perspective. Crit Rev Oncol Hematol. 2016 Mar;99:134–140. doi: 10.1016/j.critrevonc.2015.12.010.S1040-8428(15)30099-8
    1. Thornton LM, Andersen BL, Carson WE. Immune, endocrine, and behavioral precursors to breast cancer recurrence: A case-control analysis. Cancer Immunol Immunother. 2008 Oct;57(10):1471–1481. doi: 10.1007/s00262-008-0485-6.
    1. Rogers LQ, Vicari S, Trammell R, Hopkins-Price P, Fogleman A, Spenner A, Rao K, Courneya KS, Hoelzer KS, Robbs R, Verhulst S. Biobehavioral factors mediate exercise effects on fatigue in breast cancer survivors. Med Sci Sports Exerc. 2014 Jun;46(6):1077–1088. doi: 10.1249/MSS.0000000000000210.
    1. Masiero M, Riva S, Fioretti C, Pravettoni G. Pediatric blood cancer survivors and tobacco use across adolescence and emerging adulthood: A narrative review. Front Psychol. 2016;7:392. doi: 10.3389/fpsyg.2016.00392. doi: 10.3389/fpsyg.2016.00392.
    1. Poikonen-Saksela P. Bouncing back from breast cancer. EU Research. 2021. [2022-07-12]. .
    1. Chiorri C, Bracco F, Piccinno T, Modafferi C, Battini V. Psychometric properties of a revised version of the Ten Item Personality Inventory. Eur J Psychol Assess. 2015 May;31(2):109–119. doi: 10.1027/1015-5759/a000215.
    1. Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): A reevaluation of the Life Orientation Test. J Pers Soc Psychol. 1994 Dec;67(6):1063–1078. doi: 10.1037//0022-3514.67.6.1063.
    1. Antonovsky A. The structure and properties of the sense of coherence scale. Soc Sci Med. 1993 Mar;36(6):725–733. doi: 10.1016/0277-9536(93)90033-z.
    1. Weathers FW, Litz BT, Herman DS, Huska JA, Keane TM. The PTSD Checklist (PCL): Reliability, validity, and diagnostic utility. Proceedings of the 9th Annual Meeting of the International Society for Traumatic Stress Studies; The 9th Annual Meeting of the International Society for Traumatic Stress Studies; October 24-27, 1993; San Antonio, TX. 1993.
    1. Bonanno GA, Pat-Horenczyk R, Noll J. Coping flexibility and trauma: The Perceived Ability to Cope With Trauma (PACT) scale. Psychol Trauma. 2011;3(2):117–129. doi: 10.1037/a0020921.
    1. Garnefski N, Kraaij V. The Cognitive Emotion Regulation Questionnaire. Eur J Psychol Assess. 2007 Jan;23(3):141–149. doi: 10.1027/1015-5759.23.3.141.
    1. Carlson LE, Brown KW. Validation of the Mindful Attention Awareness Scale in a cancer population. J Psychosom Res. 2005 Jan;58(1):29–33. doi: 10.1016/j.jpsychores.2004.04.366.S0022-3999(04)00479-9
    1. Moser A, Stuck AE, Silliman RA, Ganz PA, Clough-Gorr KM. The eight-item modified Medical Outcomes Study Social Support Survey: Psychometric evaluation showed excellent performance. J Clin Epidemiol. 2012 Oct;65(10):1107–1116. doi: 10.1016/j.jclinepi.2012.04.007. S0895-4356(12)00116-3
    1. Connor KM, Davidson JRT. Development of a new resilience scale: The Connor-Davidson Resilience Scale (CD-RISC) Depress Anxiety. 2003;18(2):76–82. doi: 10.1002/da.10113.
    1. Weinman J, Petrie KJ, Moss-morris R, Horne R. The illness perception questionnaire: A new method for assessing the cognitive representation of illness. Psychol Health. 1996 Mar;11(3):431–445. doi: 10.1080/08870449608400270.
    1. Broadbent E, Petrie KJ, Main J, Weinman J. The Brief Illness Perception Questionnaire. J Psychosom Res. 2006 Jun;60(6):631–637. doi: 10.1016/j.jpsychores.2005.10.020.S0022-3999(05)00491-5
    1. Watson M, Greer S, Young J, Inayat Q, Burgess C, Robertson B. Development of a questionnaire measure of adjustment to cancer: The MAC scale. Psychol Med. 1988 Feb;18(1):203–209. doi: 10.1017/s0033291700002026.
    1. Merluzzi TV, Philip EJ, Heitzmann Ruhf CA, Liu H, Yang M, Conley CC. Self-efficacy for coping with cancer: Revision of the Cancer Behavior Inventory (Version 3.0) Psychol Assess. 2018 Apr;30(4):486–499. doi: 10.1037/pas0000483. 2017-21370-001
    1. Tedeschi R, Calhoun L. The Posttraumatic Growth Inventory: Measuring the positive legacy of trauma. J Trauma Stress. 1996;9(3):455–471. doi: 10.1002/jts.2490090305.
    1. Dewolf L, Koller M, Velikova G, Johnson C, Scott N, Bottomley A, EORTC Quality of Life Group . EORTC Quality of Life Group Translation Procedure. Brussels, Belgium: EORTC Quality of Life Group; 2009. Mar, [2022-06-10]. .
    1. Simard S, Savard J. Screening and comorbidity of clinical levels of fear of cancer recurrence. J Cancer Surviv. 2015 Sep;9(3):481–491. doi: 10.1007/s11764-015-0424-4.
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Thompson ER. Development and validation of an internationally reliable short-form of the Positive and Negative Affect Schedule (PANAS) J Cross Cult Psychol. 2016 Jul 26;38(2):227–242. doi: 10.1177/0022022106297301.
    1. Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma: A pilot study. Cancer. 1998 May 15;82(10):1904–1908. doi: 10.1002/(sici)1097-0142(19980515)82:10<1904::aid-cncr13>;2-x.10.1002/(SICI)1097-0142(19980515)82:10<1904::AID-CNCR13>;2-X
    1. BOUNCE Project. [2022-06-10].
    1. Engel GL. From biomedical to biopsychosocial. Being scientific in the human domain. Psychosomatics. 1997;38(6):521–528. doi: 10.1016/S0033-3182(97)71396-3.S0033-3182(97)71396-3
    1. Berry LL, Seiders K, Wilder SS. Innovations in access to care: A patient-centered approach. Ann Intern Med. 2003 Oct 07;139(7):568–574. doi: 10.7326/0003-4819-139-7-200310070-00009.139/7/568
    1. McCormack LA, Treiman K, Rupert D, Williams-Piehota P, Nadler E, Arora NK, Lawrence W, Street RL. Measuring patient-centered communication in cancer care: A literature review and the development of a systematic approach. Soc Sci Med. 2011 Apr;72(7):1085–1095. doi: 10.1016/j.socscimed.2011.01.020.S0277-9536(11)00063-3
    1. Syrjala KL, Chapko ME. Evidence for a biopsychosocial model of cancer treatment-related pain. Pain. 1995 Apr;61(1):69–79. doi: 10.1016/0304-3959(94)00153-6.00006396-199504000-00011
    1. Tramonti F, Giorgi F, Fanali A. Systems thinking and the biopsychosocial approach: A multilevel framework for patient‐centred care. Syst Res Behav Sci. 2020 Jul 15;38(2):215–230. doi: 10.1002/sres.2725.
    1. Gorini A, Mazzocco K, Gandini S, Munzone E, McVie G, Pravettoni G. Development and psychometric testing of a breast cancer patient-profiling questionnaire. Breast Cancer. 2015 Jun;:133. doi: 10.2147/bctt.s80014.
    1. Kondylakis H, Bucur A, Dong F, Renzi C, Manfrinati A, Graf N, Hoffman S, Koumakis L, Pravettoni G, Marias K, Tsiknakis M, Kiefer S. iManageCancer: Developing a platform for empowering patients and strengthening self-management in cancer diseases. Proceedings of the IEEE 30th International Symposium on Computer-Based Medical Systems; The IEEE 30th International Symposium on Computer-Based Medical Systems; June 22-24, 2017; Thessaloniki, Greece. 2017. pp. 755–760.
    1. Triberti S, Savioni L, Sebri V, Pravettoni G. eHealth for improving quality of life in breast cancer patients: A systematic review. Cancer Treat Rev. 2019 Mar;74:1–14. doi: 10.1016/j.ctrv.2019.01.003.S0305-7372(19)30007-6

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel